Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06974409 · ClinicalTrials.gov registry record · NA
This Study Will Compare Force Production in Double-leg Squats of College Students Before and After a Standardized Foam Rolling Session
A NA study, sponsored by University of Redlands.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT06974409: Completed NA study, sponsored by University of Redlands.
NCT06974409 is a NA study that has completed, run by University of Redlands. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06974409, a NA study, has completed, sponsored by University of Redlands.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This study is a within-subject controlled trial . The investigators will compare unilateral force production in a bodyweight double-leg squat before and after a standardized foam rolling session with the use of Vald ForceDecks. TheForceDecks use sensors embedded within separate plates to record the forces exerted. Participants will have their weight, height, and dorsiflexion range of motion measured prior to performing 3 double-leg squats. Participants will then be instructed on the foam rolling technique. They will perform the technique on each quadriceps group and will state their pain level at 30 seconds and at 2 minutes using the VAS pain scale.
Primary Outcome
Unilateral lower extremity force production during a single-leg squat.
Interventions
- DEVICE foam roller
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2025-06-11 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
What the finished NCT06974409 record still lists
NCT06974409 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which foam roller is the first listed.
NCT06974409 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06974409 about?
NCT06974409 is a clinical study titled "This Study Will Compare Force Production in Double-leg Squats of College Students Before and After a Standardized Foam Rolling Session". This study is a within-subject controlled trial . The investigators will compare unilateral force production in a bodyweight double-leg squat before and after a standardized foam rolling session with the use of Vald ForceDecks. TheForceDecks use sensors embedded within separate plates to record the ...
What is the current status of trial NCT06974409?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2025-06-11. Estimated completion is 2025-09-30.
What interventions are being tested in trial NCT06974409?
The interventions under investigation include: foam roller (DEVICE).
Who is sponsoring clinical trial NCT06974409?
This trial is sponsored by University of Redlands, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06974409's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI